Oncolytics Biotech Inc.
NASDAQ:ONCY
0.9302 (USD) • At close January 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.852 | 0 | 0 | 0 | 0 | 0 | 0 | 0.783 | 0.7 | 0.313 | 0.209 | 0 | 0.31 | 0 |
| Cost of Revenue
| 0.403 | 0.392 | 0.452 | 0.446 | 0.486 | 0.095 | 0.091 | 0.162 | 0.18 | 0 | 0 | 4.852 | 5.335 | 4.19 | 3.783 | 4.312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.403 | -0.392 | -0.452 | -0.446 | -0.486 | -0.095 | -0.091 | -0.162 | -0.18 | 0 | 0 | 0 | -5.335 | -4.19 | -3.783 | -4.312 | 0 | 0 | 0.783 | 0.7 | 0.313 | 0.209 | 0 | 0.31 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Reseach & Development Expenses
| 17.709 | 15.432 | 12.92 | 12.945 | 11.135 | 9.418 | 9.393 | 9.77 | 8.602 | 13.824 | 18.506 | 31.403 | 23.387 | 12.192 | 12.153 | 13.352 | 11.315 | 10.536 | 9.309 | 7.108 | 3.314 | 4.284 | 5.117 | 3.69 | 0.487 |
| General & Administrative Expenses
| 16.082 | 11.492 | 13.315 | 12.514 | 0 | 0 | 0 | 5.362 | 5.135 | 0 | 0.373 | 0.731 | 1.137 | 3.251 | 4.405 | 0.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | -0.452 | -0.446 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 16.082 | 11.492 | 12.863 | 12.068 | 8.84 | 7.082 | 6.213 | 5.362 | 5.135 | 4.999 | 0.373 | 0.731 | 1.137 | 3.251 | 4.405 | 0.064 | 4.527 | 4.034 | 3.149 | 5.472 | 2.954 | 2.102 | 1.555 | 1.061 | 0.089 |
| Other Expenses
| 0 | 0 | 13.315 | 12.514 | 9.559 | 7.245 | 6.213 | 0.162 | 0.18 | 4.999 | 5.02 | 4.555 | 0 | 0.41 | 0.425 | 0.342 | 5.53 | 4.96 | 4.005 | 6.224 | 3.617 | 2.677 | 2.021 | 1.266 | 0.091 |
| Operating Expenses
| 33.791 | 26.924 | 26.235 | 25.459 | 20.693 | 16.663 | 15.605 | 15.295 | 13.918 | 18.823 | 23.899 | 36.688 | 28.721 | 15.506 | 17.004 | 13.758 | 16.845 | 15.496 | 13.314 | 13.332 | 6.932 | 6.96 | 7.137 | 4.956 | 0.577 |
| Operating Income
| -33.791 | -28.569 | -26.235 | -25.459 | -20.693 | -16.663 | -15.605 | -15.295 | -13.918 | -18.823 | -23.899 | -36.688 | -28.721 | -20.043 | -17.004 | -18.069 | -16.845 | -15.496 | -12.531 | -12.632 | -6.618 | -6.751 | -7.137 | -4.646 | -0.577 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.562 | 0 | 0 | 0 | 0 | 0 | 0 | -15.994 | -18.052 | -21.124 | -32.324 | 0 | -14.986 | -577,370 |
| Total Other Income Expenses Net
| 6.136 | 2.173 | -0.02 | 2.954 | -12.43 | 0.173 | 0.13 | 0.164 | 0.198 | 0.21 | 0.371 | 0.345 | -0.283 | 0.077 | 0.031 | 0.519 | 1.203 | 1.199 | 0.529 | -0.324 | -1.892 | 0 | 0.655 | 0.906 | 0 |
| Income Before Tax
| -27.655 | -24.751 | -26.255 | -22.505 | -33.123 | -16.489 | -15.475 | -15.131 | -13.72 | -18.613 | -23.527 | -36.343 | -29.005 | -19.966 | -16.973 | -17.55 | -15.642 | -14.298 | -12.783 | -12.956 | -8.51 | -6.751 | -6.482 | -3.74 | 0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.491 | 0 | 0 | 0 | 0 | 0 | 0 | -16.317 | -18.515 | -27.164 | -32.324 | 0 | -12.064 | 0 |
| Income Tax Expense
| 0.097 | 0.084 | 0.049 | -2.954 | 12.43 | 0.548 | 0.141 | 0.009 | 0.003 | 0.007 | 0.005 | 0.03 | 0.04 | 0.008 | 0.023 | 0 | -1.203 | -1.199 | -0.002 | 0.324 | 0.034 | -0.66 | -0.311 | -0.127 | -0.003 |
| Net Income
| -27.752 | -24.835 | -26.304 | -19.551 | -45.552 | -17.037 | -15.617 | -15.14 | -13.723 | -18.619 | -23.533 | -36.374 | -29.045 | -19.974 | -16.996 | -17.55 | -15.642 | -14.298 | -12.782 | -12.956 | -8.544 | -6.091 | -6.171 | -3.613 | -0.574 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.497 | 0 | 0 | 0 | 0 | 0 | 0 | -16.315 | -18.515 | -27.271 | -29.164 | 0 | -11.655 | -574,462 |
| EPS
| -0.41 | -0.43 | -0.49 | -0.48 | -2.06 | -1.06 | -1.12 | -1.2 | -1.16 | -2.01 | -2.68 | -4.54 | -3.89 | -3.04 | -3.27 | -4.03 | -3.68 | -3.74 | -3.71 | -4.31 | -3.48 | -2.74 | -3.17 | -2.09 | -0.93 |
| EPS Diluted
| -0.41 | -0.43 | -0.49 | -0.48 | -2.06 | -1.06 | -1.12 | -1.2 | -1.16 | -2.01 | -2.68 | -4.54 | -3.89 | -3.04 | -3.27 | -4.03 | -3.68 | -3.74 | -3.71 | -4.31 | -3.48 | -2.74 | -3.17 | -1.98 | -0.93 |
| EBITDA
| -33.71 | -26.831 | -25.664 | -25.37 | -20.021 | -17.177 | -15.515 | -15.132 | -13.737 | -18.659 | -23.767 | -36.579 | -27.929 | -19.287 | -16.746 | -17.659 | -15.833 | -14.534 | -12.456 | -12.58 | -5.955 | -6.177 | -6.672 | -4.44 | -0.576 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.54 | 0 | 0 | 0 | 0 | 0 | 0 | -14.579 | -16.515 | -12.967 | -29.575 | 0 | -14.324 | -575,691 |